BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33515299)

  • 1. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?
    Roos-Weil D; Weiss N; Guihot A; Uzunov M; Bellanger A; Eymard B; Saadoun D; Houillier C; Idbaih A; Demeret S; Deback C; Leblond V; Galanaud D; Shor N; Pourcher V
    J Neurol; 2021 Jul; 268(7):2458-2465. PubMed ID: 33515299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review.
    Lan TY; Chen YS; Cheng CF; Huang ST; Shen CY; Hsu PN
    Lupus; 2021 Oct; 30(11):1849-1855. PubMed ID: 34325541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy.
    Beck ES; Cortese I
    Curr Opin Virol; 2020 Feb; 40():19-27. PubMed ID: 32279025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy.
    Medrano C; Vergez F; Mengelle C; Faguer S; Kamar N; Del Bello A
    Emerg Infect Dis; 2019 Nov; 25(11):2145-2147. PubMed ID: 31625858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive multifocal leukoencephalopathy treated with nivolumab.
    Hoang E; Bartlett NL; Goyal MS; Schmidt RE; Clifford DB
    J Neurovirol; 2019 Apr; 25(2):284-287. PubMed ID: 30864100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
    Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
    N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: Identifying relevant outcome factors.
    Lambert N; El Moussaoui M; Maquet P
    Eur J Neurol; 2021 Nov; 28(11):3814-3819. PubMed ID: 34251719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab.
    Varmpompiti K; Westwood AJ; Ben-Joseph A; Sibtain N; Ibrahim MAA; Stanton B; Zuckerman M; Hadden R; Ritter LM
    J Neuroimmunol; 2023 Dec; 385():578248. PubMed ID: 37995595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
    Volk T; Warnatz K; Marks R; Urbach H; Schluh G; Strohmeier V; Rojas-Restrepo J; Grimbacher B; Rauer S
    J Neurol; 2022 Feb; 269(2):973-981. PubMed ID: 34196768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors.
    Boumaza X; Bonneau B; Roos-Weil D; Pinnetti C; Rauer S; Nitsch L; Del Bello A; Jelcic I; Sühs KW; Gasnault J; Goreci Y; Grauer O; Gnanapavan S; Wicklein R; Lambert N; Perpoint T; Beudel M; Clifford D; Sommet A; Cortese I; Martin-Blondel G;
    Ann Neurol; 2023 Feb; 93(2):257-270. PubMed ID: 36151879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV.
    Corey S; Smith BR; Cortese ICM
    Curr HIV/AIDS Rep; 2022 Dec; 19(6):580-591. PubMed ID: 36181625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease.
    Cortese I; Reich DS; Nath A
    Nat Rev Neurol; 2021 Jan; 17(1):37-51. PubMed ID: 33219338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killing Two Birds With One Stone: Effective Control of Both Non-Small Cell Lung Cancer and Progressive Multifocal Leukoencephalopathy With Atezolizumab, A Case Report.
    Lambert N; El Moussaoui M; Ritacco C; Moïse M; Paulus A; Delvenne P; Baron F; Sadzot B; Maquet P
    Front Immunol; 2022; 13():889148. PubMed ID: 35592313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
    Holmes A; Wellings T; Walsh O; Rowlings P
    J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
    Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
    BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies.
    Hadjadj J; Guffroy A; Delavaud C; Taieb G; Meyts I; Fresard A; Streichenberger N; L'Honneur AS; Rozenberg F; D'Aveni M; Aguilar C; Rosain J; Picard C; Mahlaoui N; Lecuit M; Hermine O; Lortholary O; Suarez F
    J Clin Immunol; 2019 Jan; 39(1):55-64. PubMed ID: 30552536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
    Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive multifocal leukoencephalopathy.
    Weissert R
    J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovative therapeutic concepts of progressive multifocal leukoencephalopathy.
    Möhn N; Grote-Levi L; Hopfner F; Eiz-Vesper B; Maecker-Kolhoff B; Warnke C; Sühs KW; Wattjes MP; Höglinger GU; Skripuletz T
    J Neurol; 2022 May; 269(5):2403-2413. PubMed ID: 34994851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemma.
    Baena-Álvarez B; Rodríguez-Jorge F; Beltrán-Corbellini Á; Cortés-Salgado A; De la Puente C; Corral Í
    J Neurovirol; 2023 Feb; 29(1):116-119. PubMed ID: 36348234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.